Medicines Scheduling

Medical cannabis and its health market potential was first brought to the attention of Australian pharmacists by i2P as far [...]

The codeine debacle has come and gone, and I’m not sure if our profession has come out of this squeaky clean. Judging by [...]

The American Academy for Anti-Ageing (A4M) is a medical group researching and treating the ageing process through utilising [...]

I2P has been proactive in identifying the potential of medical cannabis as a tool for clinical pharmacists and a useful [...]

Editor’s Note: As most i2P subscribers would know, we carry a range of information on diverse topics, one of which is [...]

Medicinal cannabis will become legal, but strictly controlled from November this year, under a formal decision reached by [...]

New technologies pave the way for innovation to drive business practices in pharmacy. Unfortunately, innovation appears to [...]

This report is a collection of news items and research reports related to the effects of medical cannabis. Some of this [...]

Dear Colleagues, BMJ article: increasing overdoses but they ignore known solutions (+ Hari TED talk). There is no more [...]

The Australian Government intends to amend the Narcotic Drugs Act to allow cannabis to be grown for medicine or science and [...]

1 2 »